MyFinsight
Home
Blog
About
Apex-Header-svg
Elevance Health, Inc. (ELV)
Apex-Header-svg
Elevance Health, Inc. (ELV)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$1,626M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Proceeds from sale of investment...
Net income
Accounts payable and other liabi...
Others
Negative Cash Flow Breakdown
Purchases of investments
Repayments of short-term borrowi...
Receivables, net
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
1,454
1,760
546
1,187
Net losses on financial instruments
-56
-78
-57
-1
Gain on sale of business
-
-
0
0
Equity in net earnings of other invested assets
262
305
147
113
Depreciation and amortization
366
354
406
387
Deferred income taxes
151
-274
-322
269
Impairment of property and equipment
33
4
38
70
Share-based compensation
75
55
30
84
Receivables, net
657
1,174
-756
-815
Other invested assets
0
0
-70
35
Other assets
-111
1,552
-460
-201
Policy liabilities
-374
1,590
1,101
-1,260
Unearned income
-119
266
-338
270
Accounts payable and other liabilities
1,238
2,886
-2,259
-151
Income taxes
-156
644
-284
-616
Other, net
3
-
30
-26
Net cash provided by operating activities
1,913
4,332
84
1,135
Purchases of investments
3,132
4,735
2,761
4,163
Proceeds from sale of investments
2,976
3,094
2,666
2,975
Maturities, calls and redemptions from investments
432
552
576
447
Changes in securities lending collateral
-171
313
-191
110
Purchases of subsidiaries, net of cash acquired
0
-5
-33
-1
Proceeds from sales of subsidiaries, net of cash sold
-
-
0
0
Purchases of property and equipment
287
235
293
360
Other, net
1
10
-52
14
Net cash used in investing activities
159
-1,642
464
-1,224
Proceeds from long-term borrowings, net issuance costs
-
-
-3
2,994
Repayments of long-term borrowings
0
750
-3
900
Proceeds from short-term borrowings
101
724
515
990
Repayments of short-term borrowings
825
150
545
1,170
Changes in securities lending payable
-171
313
-190
110
Changes in bank overdrafts
-29
-1,152
1,235
-554
Repurchase and retirement of common stock
234
1,124
471
876
Cash dividends
373
376
377
381
Proceeds from issuance of common stock under employee stock plans
26
37
58
0
Taxes paid through withholding of common stock under employee stock plans
1
34
1
-9
Other, net
12
-3
12
21
Net cash used in financing activities
-1,494
-2,515
236
243
Effect of foreign exchange rates on cash and cash equivalents
-3
-9
-6
-1
Change in cash and cash equivalents
575
166
778
153
Cash and cash equivalents at beginning of period
9,657
9,491
7,500
7,500
Less cash and cash equivalents included in assets held for sale at end of year
-
-
0
0
Cash and cash equivalents at end of period
10,232
9,657
9,491
8,713
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$1,454M
(-16.63%↓ Y/Y)
Accounts payable and
other liabilities
$1,238M
(67.75%↑ Y/Y)
Proceeds from sale of
investments
$2,976M
(-15.77%↓ Y/Y)
Depreciation and
amortization
$366M
(-3.68%↓ Y/Y)
Deferred income taxes
$151M
(390.38%↑ Y/Y)
Other assets
-$111M
(-158.14%↓ Y/Y)
Share-based compensation
$75M
(-7.41%↓ Y/Y)
Net losses on
financial instruments
-$56M
(57.25%↑ Y/Y)
Impairment of property and
equipment
$33M
Maturities, calls and
redemptions from...
$432M
(33.33%↑ Y/Y)
Changes in securities
lending collateral
-$171M
(-197.16%↓ Y/Y)
Net cash provided by
operating activities
$1,913M
(-6.86%↓ Y/Y)
Net cash used in
investing activities
$159M
(123.14%↑ Y/Y)
Canceled cashflow
$1,571M
Canceled cashflow
$3,420M
Change in cash and cash
equivalents
$575M
(-45.75%↓ Y/Y)
Canceled cashflow
$1,497M
Receivables, net
$657M
(-28.82%↓ Y/Y)
Policy liabilities
-$374M
(-75.59%↓ Y/Y)
Equity in net earnings
of other invested...
$262M
(2083.33%↑ Y/Y)
Income taxes
-$156M
(-163.41%↓ Y/Y)
Unearned income
-$119M
(-50.63%↓ Y/Y)
Other, net
$3M
(0.00%↑ Y/Y)
Proceeds from short-term
borrowings
$101M
Proceeds from issuance of
common stock under...
$26M
(1400.00%↑ Y/Y)
Other, net
$12M
(300.00%↑ Y/Y)
Purchases of investments
$3,132M
(-24.31%↓ Y/Y)
Purchases of property and
equipment
$287M
(7.49%↑ Y/Y)
Other, net
$1M
(-92.31%↓ Y/Y)
Net cash used in
financing activities
-$1,494M
(-385.06%↓ Y/Y)
Effect of foreign
exchange rates on cash and...
-$3M
(-400.00%↓ Y/Y)
Canceled cashflow
$139M
Repayments of short-term
borrowings
$825M
(850.00%↑ Y/Y)
Cash dividends
$373M
(-3.12%↓ Y/Y)
Repurchase and retirement
of common stock
$234M
(-38.10%↓ Y/Y)
Changes in securities
lending payable
-$171M
(-197.16%↓ Y/Y)
Changes in bank
overdrafts
-$29M
(-134.12%↓ Y/Y)
Taxes paid through
withholding of common stock...
$1M
(101.20%↑ Y/Y)
Buy us a coffee
Show more